99mTc-DARPinG3-based HER2 Expression Molecular Imaging in HER2-positive Breast Cancer During Chemo+Targeted Therapy
Clinical trial NCT05412459 · COMPLETED
Trial details
- NCT number
- NCT05412459
- Sponsor
- Tomsk National Research Medical Center of the Russian Academy of Sciences
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-01
- Primary completion
- 2022-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.